Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer

Article metrics

Abstract

We conducted a two-stage genome-wide association study of pancreatic cancer, a cancer with one of the lowest survival rates worldwide. We genotyped 558,542 SNPs in 1,896 individuals with pancreatic cancer and 1,939 controls drawn from 12 prospective cohorts plus one hospital-based case-control study. We conducted a combined analysis of these groups plus an additional 2,457 affected individuals and 2,654 controls from eight case-control studies, adjusting for study, sex, ancestry and five principal components. We identified an association between a locus on 9q34 and pancreatic cancer marked by the SNP rs505922 (combined P = 5.37 × 10−8; multiplicative per-allele odds ratio 1.20; 95% confidence interval 1.12–1.28). This SNP maps to the first intron of the ABO blood group gene. Our results are consistent with earlier epidemiologic evidence suggesting that people with blood group O may have a lower risk of pancreatic cancer than those with groups A or B.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Manhattan plot of the P values in the pancreatic cancer GWAS.
Figure 2: Association and linkage disequilibrium plot of the 9q34 locus.

References

  1. 1

    Jemal, A. et al. Cancer statistics, 2008. CA Cancer J. Clin. 58, 71–96 (2008).

  2. 2

    Ferlay, J., Bray, F., Pisani, P. & Parkin, D.M. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, IARCPress, Lyon (2004).

  3. 3

    Anderson, K.E., Mack, T. & Silverman, D. Cancer of the pancreas. in Cancer Epidemiology and Prevention (ed. Schottenfeld, D. & Fraumeni, J.J.) (Oxford Univ. Press, New York, 2006).

  4. 4

    Lowenfels, A.B. et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J. Natl. Cancer Inst. 89, 442–446 (1997).

  5. 5

    Castleman, B. Case records of the Massachusetts General Hospital. N. Engl. J. Med. 286, 1353–1359 (1972).

  6. 6

    Klein, A.P. et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 64, 2634–2638 (2004).

  7. 7

    Calle, E.E. et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 94, 2490–2501 (2002).

  8. 8

    The ATBC Cancer Prevention Study Group. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann. Epidemiol. 4, 1–10 (1994).

  9. 9

    Riboli, E. et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 5, 1113–1124 (2002).

  10. 10

    Gallicchio, L. et al. Single nucleotide polymorphisms in inflammation-related genes and mortality in a community-based cohort in Washington County, Maryland. Am. J. Epidemiol. 167, 807–813 (2008).

  11. 11

    Wolpin, B.M. et al. Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer. Cancer Res. 67, 7923–7928 (2007).

  12. 12

    Zeleniuch-Jacquotte, A. et al. Postmenopausal levels of sex hormones and risk of breast carcinoma in situ: results of a prospective study. Int. J. Cancer 114, 323–327 (2005).

  13. 13

    Hayes, R.B. et al. Methods for etiologic and early marker investigations in the PLCO trial. Mutat. Res. 592, 147–154 (2005).

  14. 14

    Xu, W.H. et al. Joint effect of cigarette smoking and alcohol consumption on mortality. Prev. Med. 45, 313–319 (2007).

  15. 15

    Zheng, W. et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am. J. Epidemiol. 162, 1123–1131 (2005).

  16. 16

    Anderson, G.L. et al. Implementation of the Women's Health Initiative study design. Ann. Epidemiol. 13, S5–S17 (2003).

  17. 17

    Rexrode, K.M., Lee, I.M., Cook, N.R., Hennekens, C.H. & Buring, J.E. Baseline characteristics of participants in the Women's Health Study. J. Womens Health Gend. Based Med. 9, 19–27 (2000).

  18. 18

    McWilliams, R.R. et al. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res. 68, 4928–4935 (2008).

  19. 19

    Eppel, A., Cotterchio, M. & Gallinger, S. Allergies are associated with reduced pancreas cancer risk: A population-based case-control study in Ontario, Canada. Int. J. Cancer 121, 2241–2245 (2007).

  20. 20

    Duell, E.J. et al. Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 17, 1470–1479 (2008).

  21. 21

    Hassan, M.M. et al. Risk factors for pancreatic cancer: case-control study. Am. J. Gastroenterol. 102, 2696–2707 (2007).

  22. 22

    Olson, S.H. et al. Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer. Cancer Detect. Prev. 31, 345–351 (2007).

  23. 23

    Risch, H.A. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J. Natl. Cancer Inst. 95, 948–960 (2003).

  24. 24

    Skol, A.D., Scott, L.J., Abecasis, G.R. & Boehnke, M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 38, 209–213 (2006).

  25. 25

    Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).

  26. 26

    Aird, I., Bentall, H.H. & Roberts, J.A. A relationship between cancer of stomach and the ABO blood groups. BMJ 1, 799–801 (1953).

  27. 27

    Marcus, D.M. The ABO and Lewis blood-group system. Immunochemistry, genetics and relation to human disease. N. Engl. J. Med. 280, 994–1006 (1969).

  28. 28

    Melzer, D. et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet. 4, e1000072 (2008).

  29. 29

    Paré, G. et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet. 4, e1000118 (2008).

  30. 30

    Yuan, X. et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am. J. Hum. Genet. 83, 520–528 (2008).

  31. 31

    Itzkowitz, S.H. et al. Cancer-associated alterations of blood group antigen expression in the human pancreas. J. Natl. Cancer Inst. 79, 425–434 (1987).

  32. 32

    Berman, D.M. et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425, 846–851 (2003).

  33. 33

    Wolpin, B.M. et al. ABO blood group and the risk of pancreatic cancer. J. Natl. Cancer Inst. 101, 424–431 (2009).

  34. 34

    Wigginton, J.E., Cutler, D.J. & Abecasis, G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am. J. Hum. Genet. 76, 887–893 (2005).

  35. 35

    Pritchard, J.K., Stephens, M. & Donnelly, P. Inference of population structure using multilocus genotype data. Genetics 155, 945–959 (2000).

  36. 36

    Frazer, K.A. et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851–861 (2007).

  37. 37

    Thomas, G. et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet. 40, 310–315 (2008).

  38. 38

    Hunter, D.J. et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 39, 870–874 (2007).

  39. 39

    Yu, K. et al. Population substructure and control selection in genome-wide association studies. PLoS One 3, e2551 (2008).

  40. 40

    Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).

  41. 41

    Patterson, N., Price, A.L. & Reich, D. Population structure and eigenanalysis. PLoS Genet. 2, e190 (2006).

  42. 42

    Sun, L., Wilder, K. & McPeek, M.S. Enhanced pedigree error detection. Hum. Hered. 54, 99–110 (2002).

  43. 43

    Lettre, G., Lange, C. & Hirschhorn, J.N. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet. Epidemiol. 31, 358–362 (2007).

  44. 44

    Higgins, J.P. & Thompson, S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539–1558 (2002).

Download references

Acknowledgements

The authors gratefully acknowledge the energy and contribution of our late colleague, Robert Welch. Additional acknowledgments are found in the Supplementary Note.

Author information

L.A., P.K., R.Z.S.-S., C.S.F., G.M.P., K.B.J., S.M.L., J.B.M., G.S.T., S.J.C., P.H. and R.N.H. organized and designed the study. L.A., A.H., K.B.J., G.T. and S.J.C. supervised genotyping of samples. L.A., P.K., R.Z.S.-S., C.S.F., K.B.J., C.K., K.Y., S.J.C., P.H. and R.N.H. contributed to the design and execution of statistical analysis. LA., S.J.C., P.H. and R.N.H. wrote the first draft of the manuscript. R.Z.S.-S., C.S.F., G.M.P., A.A.A., H.B.B.-d.-M., M.G., K.H., E.J.J., A.L., W.Z., D.A., W.B., C.D.B., F.B., S.B., J.E.B., P.M.B., F.C., F.C.-C., S.C., M.C., M.d.A., E.J.D., J.W.F., S.G., J.M.G., E.L.G., M.G., C.A.G., G.H., S.E.H., M.H., E.A.H., D.J.H., R.J., M.J., R.K., A.P.K., C.K., R.C.K., D.L., M.M., R.R.M., D.S.M., S.H.O., K.O., A.V.P., P.H.M.P., A.R., E.R., H.A.R., X.-O.S., D.T., S.K.V.D.E., J.V., J.W.-W., B.M.W., H.Y. and A.Z.-J. conducted the epidemiologic studies and contributed samples to the PanScan GWAS and/or replication. All authors contributed to the writing of the manuscript.

Correspondence to Stephen J Chanock.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–4, Supplementary Tables 1–5 and Supplementary Note (PDF 401 kb)

Rights and permissions

Reprints and Permissions

About this article

Further reading